Market revenue in 2023 | USD 89.6 million |
Market revenue in 2030 | USD 220.1 million |
Growth rate | 13.7% (CAGR from 2023 to 2030) |
Largest segment | Serum-free media |
Fastest growing segment | Serum-free Media |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Serum-free Media, Classical Media, Stem Cell Culture Media, Chemically Defined Media, Specialty Media, Other Cell Culture Media |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, BD, STEMCELL Technologies, PromoCell GmbH |
Serum-free media was the largest segment with a revenue share of 35.38% in 2023. Horizon Databook has segmented the Australia cell culture media market based on serum-free media, classical media, stem cell culture media, chemically defined media, specialty media, other cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
The Australian Regulatory Guidelines for Biologicals (ARGB) provides details on the supply and usage of tissue and human cell-based therapeutics and live animal organs, cells, and tissues. In addition, the Therapeutic Goods Administration (TGA) is accountable for regulation of products for therapeutic use, including human cells and tissues, known as biologics. This includes human stem cell treatments.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account